Extension of Time to File SOU

FIRE-LINC

Otsuka America Pharmaceutical, Inc.

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88918023
LAW OFFICE ASSIGNED LAW OFFICE 111
MARK SECTION
MARK FIRE-LINC (see, http://uspto.report/TM/88918023/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT FIRE-LINC
OWNER SECTION (current)
NAME Otsuka America Pharmaceutical, Inc.
MAILING ADDRESS 2440 Research Boulevard
CITY Rockville
STATE Maryland
ZIP/POSTAL CODE 20850
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 202-408-4000
FAX 202-408-4400
EMAIL XXXX
OWNER SECTION (proposed)
NAME Otsuka America Pharmaceutical, Inc.
MAILING ADDRESS 2440 Research Boulevard
CITY Rockville
STATE Maryland
ZIP/POSTAL CODE 20850
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
PHONE 202-408-4000
FAX 202-408-4400
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME B. Brett Heavner
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) patrice.ingram@finnegan.com
CORRESPONDENCE INFORMATION (proposed)
NAME B. Brett Heavner
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE docketing@finnegan.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) patrice.ingram@finnegan.com
DOCKET/REFERENCE NUMBER 09843.0134
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 042
CURRENT IDENTIFICATION providing online non-downloadable software applications for use in pharmaceutical clinical trial site identification, recruitment and enrollment
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 1
ALLOWANCE MAIL DATE 05/04/2021
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /karen gally/
SIGNATORY'S NAME Karen Gally
SIGNATORY'S POSITION VP & General Counsel
DATE SIGNED 10/12/2021
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Wed Oct 13 10:43:17 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.X.X-2021
1013104317252711-88918023
-7816265a9cb760f79ce6f785
6559f2671376319a28a30dd88
c9ef2757b194e6b-CC-431408
05-20211011170128349951



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: FIRE-LINC (see, http://uspto.report/TM/88918023/mark.png)
SERIAL NUMBER: 88918023

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Otsuka America Pharmaceutical, Inc., having an address of
      2440 Research Boulevard
      Rockville, Maryland 20850
      United States
      Phone: 202-408-4000
      Fax: 202-408-4400
      Email: XXXX
Proposed: Otsuka America Pharmaceutical, Inc., having an address of
      2440 Research Boulevard
      Rockville, Maryland 20850
      United States
      Phone: 202-408-4000
      Fax: 202-408-4400
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 05/04/2021.

For International Class 042:
Current identification: providing online non-downloadable software applications for use in pharmaceutical clinical trial site identification, recruitment and enrollment

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the first extension request.

Correspondence Information (current):
      B. Brett Heavner
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): patrice.ingram@finnegan.com

Correspondence Information (proposed):
      B. Brett Heavner
      PRIMARY EMAIL FOR CORRESPONDENCE: docketing@finnegan.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): patrice.ingram@finnegan.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /karen gally/      Date Signed: 10/12/2021
Signatory's Name: Karen Gally
Signatory's Position: VP & General Counsel
Signature method: Sent to third party for signature

PAYMENT: 88918023
PAYMENT DATE: 10/13/2021

Serial Number: 88918023
Internet Transmission Date: Wed Oct 13 10:43:17 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.X.X-2021101310431725271
1-88918023-7816265a9cb760f79ce6f7856559f
2671376319a28a30dd88c9ef2757b194e6b-CC-4
3140805-20211011170128349951




uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed